Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?
- PMID: 35249898
- PMCID: PMC9353850
- DOI: 10.3960/jslrt.21038
Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?
Abstract
Idiopathic multicentric Castleman disease (iMCD) is a systemic disorder characterized by systemic inflammation and organ dysfunction associated with an increase in pro-inflammatory cytokines. Some patients with iMCD are positive for autoantibodies, although their significance and relationship with specific associated autoimmune diseases are unclear. This study retrospectively analyzed the clinicopathological features of iMCD patients focusing on autoantibodies. Among 63 iMCD patients in our database, 19 were positive for at least one autoantibody. Among the 19, we identified five with plasma cell type (PC)-iMCD lymph node histopathology and positive anti-phospholipid antibodies. These patients were likely to have thrombocytopenia, anasarca, fever, reticulin fibrosis or renal insufficiency, organomegaly (TAFRO) symptoms, and thrombotic events. The present study suggests that patients with undiagnosed or atypical autoimmune diseases, including anti-phospholipid syndrome (APS), were treated for iMCD. APS may present with thrombocytopenia or even multi-organ failure, which overlap with clinical presentations of iMCD. Due to differences in the treatment regimen and follow-up, recognition of the undiagnosed autoimmune disease process in those suspected of iMCD is essential. Our study highlights the importance of complete exclusion of differential diagnoses in patients with iMCD in their diagnostic workup.
Keywords: autoimmune, anti-phospholipid syndrome; idiopathic plasmacytic lymphadenopathy; multicentric Castleman disease.
Conflict of interest statement
CONFLICT OF INTEREST
The authors declare no conflict of interest.
Figures

Similar articles
-
TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?Biomedicines. 2024 Mar 14;12(3):652. doi: 10.3390/biomedicines12030652. Biomedicines. 2024. PMID: 38540266 Free PMC article.
-
Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.Am J Hematol. 2021 Oct 1;96(10):1241-1252. doi: 10.1002/ajh.26292. Epub 2021 Jul 28. Am J Hematol. 2021. PMID: 34265103 Free PMC article.
-
Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).Pathol Int. 2019 Oct;69(10):572-579. doi: 10.1111/pin.12856. Pathol Int. 2019. PMID: 31631463
-
Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.Hematol Oncol. 2022 Apr;40(2):191-201. doi: 10.1002/hon.2969. Epub 2022 Feb 18. Hematol Oncol. 2022. PMID: 35104370 Free PMC article.
-
An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome.Pathol Res Pract. 2019 Mar;215(3):410-413. doi: 10.1016/j.prp.2018.12.025. Epub 2018 Dec 26. Pathol Res Pract. 2019. PMID: 30642741 Review.
Cited by
-
TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?Biomedicines. 2024 Mar 14;12(3):652. doi: 10.3390/biomedicines12030652. Biomedicines. 2024. PMID: 38540266 Free PMC article.
-
Diagnostic challenges in patients with Castleman disease, a single center experience from Hungary.Pathol Oncol Res. 2024 Aug 26;30:1611785. doi: 10.3389/pore.2024.1611785. eCollection 2024. Pathol Oncol Res. 2024. PMID: 39252787 Free PMC article.
-
Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease.J Clin Pathol. 2024 Feb 20:jcp-2023-209280. doi: 10.1136/jcp-2023-209280. Online ahead of print. J Clin Pathol. 2024. PMID: 38378248 Free PMC article.
-
Historical and pathological overview of Castleman disease.J Clin Exp Hematop. 2022 Jun 28;62(2):60-72. doi: 10.3960/jslrt.21036. Epub 2022 Apr 27. J Clin Exp Hematop. 2022. PMID: 35474035 Free PMC article.
-
Transcriptome analysis of the cytokine storm-related genes among the subtypes of idiopathic multicentric Castleman disease.J Clin Exp Hematop. 2024 Dec 25;64(4):297-306. doi: 10.3960/jslrt.24061. Epub 2024 Oct 28. J Clin Exp Hematop. 2024. PMID: 39462545 Free PMC article.
References
-
- Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020; 135: 1353-1364. - PubMed
-
- Takai K, Nikkuni K, Shibuya H, Hashidate H. [Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly]. Rinsho Ketsueki. 2010; 51: 320-325. - PubMed
-
- Kojima M, Nakamura S, Shimizu K, et al. Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases. Int J Surg Pathol. 2004; 12: 25-30. - PubMed